CELL SIGNALING TECHNOLOGY

What this means for you

Registered since 30 Aug 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Aug 2031: the §8 & §9 renewal).

Record

Serial number

77907992

Registration number

4017621

Mark type

Design + words

Filed

08 Jan 2010

Published for opposition

14 Jun 2011

Registered

30 Aug 2011

Current term from

30 Aug 2021

Next maintenance filing

§8 & §9 renewal, due by 30 Aug 2031 (grace period to 29 Feb 2032)

Attorney of record

Keith A. Weltsch, Esq.

Goods and services

• Class 001 — Chemicals: Reagents for scientific or medical research use, namely, antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors

Owner

• Cell Signaling Technology, Inc., Danvers, MA, US
• Cell Signaling Technology, Inc., Danvers, MA, US
• Cell Signaling Technology, Inc., Danvers, MA, US

Prior registrations

• Registration 2583920

Prosecution history

• 13 Dec 2022 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
• 10 Nov 2022 — AMENDMENT UNDER SECTION 7 - PROCESSED
• 07 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 09 Jun 2022 — TEAS SECTION 7 REQUEST RECEIVED
• 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 18 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 18 Oct 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 18 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 18 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 07 Jun 2021 — TEAS SECTION 8 & 9 RECEIVED
• 06 Mar 2021 — AMENDMENT UNDER SECTION 7 - PROCESSED
• 11 Dec 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 23 Sept 2020 — TEAS SECTION 7 REQUEST RECEIVED